Outcome of Recipients of Hematopoietic Stem Cell Transplants Who Require Intensive Care Unit Support: A Single Institution Experience

Acta Haematologica

Volumn 134, Issue 2, 2015, Pages 119-124

  Galindo Becerra, Samantha ^a,b   Labastida Mercado, Nancy ^a,b   Rosales Padrón, Jaime ^c   García Chavez, Jessica ^c   Soto Vega, Elena ^b   Rivadeneyra Espinoza, Liliana ^b   León Peña, Andres A ^a,d   Fernández Lara, Danitza ^a,c   Dominguez Cid, Monica ^e   Anthon Méndez, Javier ^e   Arizpe Bravo, Daniel ^e   Ruiz Delgado, Guillermo J ^a,b,f   Ruiz Argüelles, Guillermo J ^a,b,c,e,f  

^a CENTRO DE HEMATOLOGÍA Y MEDICINA INTERNA DE PUEBLA   (Mexico)

^b UNIVERSIDAD POPULAR AUTÓNOMA DEL ESTADO DE PUEBLA   (Mexico)

^c UNIVERSIDAD DE LAS AMÉRICAS PUEBLA   (Mexico)

^d BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^e Clinica Ruiz   (Mexico)

^f Laboratorios Clinicos de Puebla   (Mexico)

Author keywords

Allografts; Autografts; Intensive care unit; Mechanical ventilation

Indexed keywords

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APACHE; ARTICLE; ARTIFICIAL VENTILATION; AUTOLOGOUS BONE MARROW TRANSPLANTATION; ENDOTRACHEAL INTUBATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFANT; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; YOUNG ADULT; ADOLESCENT; ADVERSE EFFECTS; ALLOTRANSPLANTATION; AUTOTRANSPLANTATION; GRAFT VS HOST DISEASE; MEXICO; OUTPATIENT DEPARTMENT; PROGNOSIS; RESPIRATORY INSUFFICIENCY; RISK; SEPSIS; SURVIVAL; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALS, UNIVERSITY; HUMANS; INFANT; INTENSIVE CARE UNITS; MALE; MEXICO; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; PROGNOSIS; RESPIRATORY INSUFFICIENCY; RISK; SEPSIS; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84928731797     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000381301     Document Type: Article

References (26)

1. Price KJ, Thall PF, Kish SK, Shannon VR, Andersson BS: Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit. Am J Respir Crit Care Med 1998; 158: 876-884.
2. Molina R, Bernal T, Borges M, Zaragoza R, Bonastre J, Granada RM, Rodriguez-Borregán JC, Núñez K, Seijas I, Ayestaran I, Albaiceta GM: Ventilatory support in critically ill hematology patients with respiratory failure. Crit Care 2012; 16:R133.
3. Diaz-de-Heredia C, Moreno A, Olivé T, Iglesias J, Ortega JJ: Role of the intensive care unit in children undergoing bone marrow transplantation with life-threatening complications. Bone Marrow Transplant 1999; 24: 163-168.
4. Jackson SR, Tweeddale MG, Barnett MJ, Spinelli JJ, Sutherland HJ, Reece DE, Klingemann HG, Nantel SH, Fung HC, Toze CL, Phillips GL, Shepherd JD: Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors. Bone Marrow Transplant 1998; 21: 697-704.
5. Scales DC, Thiruchelvam D, Kiss A, Sibbald WJ, Redelmeier DA: Intensive care outcomes in bone marrow transplant recipients: a population-based cohort analysis. Crit Care 2008; 12:R77.
6. Ruiz-Delgado GJ, Ruiz-Argüelles GJ: A Mexican way to cope with stem cell transplantation. Hematology 2012; 17(suppl 1): 195-197.
7. Kessinger A, Armitage JO, Landmark JD, Smith DM, Weisenburger DD: Autologous peripheral hematopoietic stem cell transplantation restores hemopoietic function following marrow ablative therapy. Blood 1988; 71: 723-727.
8. Rivadeneyra-Espinoza L, Pérez-Romano B, González-Flores A, Guzmán-García MO, Carvajal-Armora F, Ruiz-Argüelles A: Instrument and protocol-dependent variation in the enumeration of CD34+ cells by flow cytometry. Transfusion 2006; 46: 530-536.
9. López-Otero A, Ruiz-Delgado GJ, Ruiz-Argüelles GJ: A simplified method for stem cell autografting in multiple myeloma: a single institution experience. Bone Marrow Transplant 2009; 44: 715-719.
10. Gómez-Almaguer D, Ruiz-Argüelles GJ, Ruiz-Argüelles A, González-Llano O, Cantú OE, Hernández NE: Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis. Bone Marrow Transplant 2000; 25: 131-133.
11. Gómez-Almaguer D, Ruiz-Argüelles GJ, Ruiz-Argüelles A, González-Llano O, Cantú OE, Hernández NE: Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis. Bone Marrow Transplant 2000; 25: 131-133.
12. Afessa B, Tefferi A, Hoagland HC, Letendre L, Peters SG: Outcome of recipients of bone marrow transplants who require intensive care unit support. Mayo Clin Proc 1992; 67: 117-122.
13. Pene F, Aubron C, Azoulay E, Blot F, Thiery G, Raynard B, Schlemmer B, Nitenberg G, Buzyn A, Arnaud P, Societe G, Mira JP: Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol 2006; 24: 643-649.
14. Huaringa AJ, Leyva FJ, Giralt SA, Blanco J, Signes-Costa J, Velarde H, Champlin RE: Outcome of bone marrow transplantation patients requiring mechanical ventilation. Crit Care Med 2000; 28: 1014-1017.
15. Depuydt P, Kerre T, Noens L, Nollet J, Offner F, Decruyenaere J, Benoit D: Outcome in critically ill patients with allogeneic BM of peripheral haematopoietic SCT: a single centre experience. Bone Marrow Transplant 2011; 46: 1186-1191.
16. Jacobe SJ, Hassan A, Veys P, Mok Q Outcome of children requiring admission to an intensive care unit after bone marrow transplantation. Crit Care Med 2003; 31; 1299-1305.
17. Paz HL, Crilley P, Weinar M, Brodsky I: Outcome of patients requiring medical ICU admission following bone marrow transplantation. Chest 1993; 104: 527-531.
18. Cantú-Rodríguez OG, Gutiérrez-Aguirre CH, González-Llano O, Mancías-Guerra C, Jaime-Pérez JC, Tarín-Arzaga LC, Ruiz-Delgado GJ, Sandoval-Villa CC, Marfil-Rivera J, Morales-Toquero A, Ruiz-Argüelles GJ, Gómez-Almaguer D: Outpatient allografting using non-myeloablative conditioning: the Mexican experience. Bone Marrow Transplant 2007; 40: 119-123.
19. Cantú-Rodriguez OG, Jaime-Pérez JC, Gutiérrez-Aguirre CH, Treviño-Montemayor OR, Martínez-Cabriales SA, Gómez-Peña A, López-Otero A, Ruiz-Delgado GJ, González-Llano O, Mancías-Guerra MC, Tarín-Arzaga LC, Rodríguez-Romo LN, Ruiz-Argüelles GJ, Gómez-Almaguer D: Low incidence and severity of graft-versus-host disease after outpatient allogeneic peripheral blood stem cell transplantation employing a reduced-intensity conditioning. Eur J Haematol 2011; 87: 521-530.
20. Ruiz-Argüelles GJ, Gómez-Almaguer D: Nephrotic syndrome after non-myeloablative stem cell transplantation. Br J Haematol 2006; 132: 801-802.
21. Ruiz-Argüelles GJ, Gómez-Almaguer D, López-Martínez B, Ponce-De-León S, Cantú-Rodriguez OG, Jaime-Pérez JC: No cytomegalovirus-related deaths after non-ablative stem cell allografts. Hematology 2002; 7: 95-99.
22. Ruiz-Argüelles GJ, Gómez-Rangel JD, Poncede-León S, González-Déctor L, Reyes-Núñez V, Garcés-Eisele J: The Mexican schedule to conduct allogeneic stem cell transplantation is related to a low risk of cytomegalovirus reactivation and disease. Am J Hematol 2004; 75: 200-204.
23. Ruiz-Argüelles GJ, Gómez-Almaguer D, Steensma DP: Outdated dogma? Busulfan, seizure prophylaxis and stem cell allografting. Am J Hematol 2012; 87: 941.
24. Zamora-Ortiz G, Velázquez-Sánchez-de-Cima S, Ponce-de-León S, Gutiérrez-Aguirre CH, Ruiz-Delgado GJ, Gómez-Almaguer D, Ruiz-Argüelles GJ Secondary malignancies after allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning and outpatient conduction. Hematology 2014; 19; 435-440.
25. Escobar K, Rojas P, Ernst D, Bertin P, Nervi B, Jara V, García MJ, Ocqueteau M, Sarmiento M, Ramírez P: Admission of hematopoietic cell transplantation patients to the intensive care unit at the Pontificia Universidad Católica de Chile Hospital. Biol Bone Marrow Transplant 2015; 21: 176-179.
26. Eckrich M, Pasquini M: Hematopoietic cell transplantation in Latin America. Hematology 2012; 17(suppl 1):S189-S191.